In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Mitja Lainscak
Speaker
Mitja Lainscak
Mitja Lainscak Mitja Lainscak

General Hospital Murska Sobota, Murska Sobota (Slovenia)

Specialities : Chronic Heart Failure , Pharmacology and Pharmacotherapy, Pharmacology and Pharmacotherapy, Risk Factors and Prevention, Risk Factors and Prevention

48 presentations from this speaker

Heart failure management optimisation in nursing homes using point-of-care ultrasonography: the HARMONIOUS study.

Event : HFA Discoveries 2020

  • Session : Late-Breaking Science Session 5 – Monitoring
  • Speaker : M Lainscak (Murska Sobota,SI)

High prevalence of ESC-defined heart failure in an urban community: The SOBOTA-HF study.

Event : HFA Discoveries 2020

  • Session : Late-Breaking Science Session 7 – Prevention
  • Speaker : M Lainscak (Murska Sobota,SI)

Late-Breaking Science Session 5 – Monitoring.

Event : HFA Discoveries 2020

  • Session : Late-Breaking Science Session 5 – Monitoring
  • Speaker : A Pathak (Monte Carlo,MC), M Lainscak (Murska Sobota,SI), J Lindenfeld (Nashville,US)

Late-Breaking Science Session 7 – Prevention.

Event : HFA Discoveries 2020

  • Session : Late-Breaking Science Session 7 – Prevention
  • Speaker : M Lainscak (Murska Sobota,SI), P Ponikowski (Wroclaw,PL), J Lindenfeld (Nashville,US)

Chronic pulmonary disease.

Event : Heart Failure 2019

  • Session : Clinical dilemmas in the treatment of comorbidities in heart failure
  • Speaker : M Lainscak (Murska Sobota,SI)

Chronicity and burden of hyperkalaemia in heart failure: an update.

Event : ESC Congress 2019

  • Session : Towards the state-of-the-art potassium control in patients with heart failure: are we there yet? (EBAC accredited)
  • Speaker : M Lainscak (Murska Sobota,SI)
  • Supported by an unrestricted educational grant from AstraZeneca

How to implement the guidelines.

Event : Heart Failure 2019

  • Session : Guidelines in Daily Practice IV: patient with acute heart failure and pulmonary embolism.
  • Speaker : M Lainscak (Murska Sobota,SI)

How to implement the guidelines?

Event : Heart Failure 2019

  • Session : Guidelines in Daily Practice I: Potassium binders
  • Speaker : M Lainscak (Murska Sobota,SI)

Hyperkalaemia and heart failure therapy: maximising RAASi.

Event : Webinar 2019

  • Session : HFA Webinars 2019
  • Speaker : M Lainscak (Murska Sobota,SI), GMC Rosano (London,GB), P Seferovic (Belgrade,RS)

Hyperkalaemia in patients with heart failure – Addressing the unmet medical need.

Event : Heart Failure 2019

  • Session : Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy
  • Speaker : M Lainscak (Murska Sobota,SI)
  • Organised by MedEd Global Solutions & University of Lorraine, supported with an educational grant from Vifor Pharma

My atrial fibrillation patient does not respond to rate control or ablation

Event : ESC Congress 2019

  • Session : Hard to diagnose and hard to treat heart failure patients.
  • Speaker : M Lainscak (Murska Sobota,SI)

Patients in the ESC guidelines: the emerging role.

Event : Heart Failure 2019

  • Session : Patient and family engagement: compelling need for improvement
  • Speaker : M Lainscak (Murska Sobota,SI)

Potassium and heart failure.

Event : Webinar 2019

  • Session : HFA Webinars 2019
  • Speaker : S Anker (Berlin,DE), J Cleland (Glasgow,GB), M Lainscak (Murska Sobota,SI), F Zannad (Vandoeuvre,FR)

Team Presentation.

Event : Heart Failure 2019

  • Session : HFA Championships
  • Speaker : M Lainscak (Murska Sobota,SI)

Towards the state-of-the-art potassium management in heart failure: opportunities and challenges.

Event : ESC Congress 2019

  • Session : Towards the state-of-the-art potassium control in patients with heart failure: are we there yet? (EBAC accredited)
  • Speaker : S Anker (Berlin,DE), M Kosiborod (Kansas,US), M Lainscak (Murska Sobota,SI)
  • Supported by an unrestricted educational grant from AstraZeneca

Chronic obstructive lung disease

Event : Heart Failure 2018

  • Session : Managing comorbidities in heart failure
  • Speaker : M Lainscak (Murska Sobota,SI)

Depressive symptoms are major determinant of restricted health-related quality of life in patients with heart failure

Event : ESC Congress 2018

  • Session : Stress, psycho-social and cultural aspects of heart disease and depression and heart disease
  • Speaker : M Lainscak (Murska Sobota,SI)

Epidemiology in Slovenia

Event : Heart Failure 2018

  • Session : Heart failure as a major local and global challenge in the 21st century
  • Speaker : M Lainscak (Murska Sobota,SI)

Left ventricular dysfunction and heart failure in general population

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : M Lainscak (Murska Sobota,SI)

Natriuretic peptide screening in general population aged >55 years: findings from the SOBOTA-HF study

Event : Heart Failure 2018

  • Session : Late breaking trial IV - Registries
  • Speaker : M Lainscak (Murska Sobota,SI)

Nutritional problems in chronic patients - predictor of outcome.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2018

  • Session : Nutrition in disease and rehabilitation - What do you need to know?
  • Speaker : M Lainscak (Murska Sobota,SI)

Pharmacodynamic differences between generic and brand name drugs in heart failure

Event : ESC Congress 2018

  • Session : Are generic drugs safe in heart failure ?
  • Speaker : M Lainscak (Murska Sobota,SI)

Pulmonary function testing in heart failure patients

Event : Heart Failure 2018

  • Session : Chronic Heart Failure - Clinical
  • Speaker : M Lainscak (Murska Sobota,SI)

Treatment options - What do the Guidelines say?

Event : Heart Failure 2018

  • Session : Potassium - Friend or foe?
  • Speaker : M Lainscak (Murska Sobota,SI)

Discussion.

Event : Heart Failure 2017

  • Session : The concept of timing in the therapeutic algorithm for chronic heart failure
  • Speaker : M Lainscak (Murska Sobota,SI), M Boehm (Homburg,DE)
  • Sponsored by SERVIER

Gaps in evidence

Event : Heart Failure 2017

  • Session : Guidelines in Daily Practice II: hospital discharge and outpatient management
  • Speaker : M Lainscak (Murska Sobota,SI)

How to approach COPD in heart failure.

Event : Heart Failure 2017

  • Session : Attention needed for comorbidities
  • Speaker : M Lainscak (Murska Sobota,SI)

How to approach COPD in heart failure.

Event : Heart Failure 2017

  • Session : How should comorbidities in heart failure be treated?
  • Speaker : M Lainscak (Murska Sobota,SI)

Importance of prompt management for heart failure patients.

Event : Heart Failure 2017

  • Session : The concept of timing in the therapeutic algorithm for chronic heart failure
  • Speaker : M Lainscak (Murska Sobota,SI)
  • Sponsored by SERVIER

Person centred care: the physicians view.

Event : EuroHeartCare 2017

  • Session : Putting the patient at the centre of Person-centred Health Care
  • Speaker : M Lainscak (Murska Sobota,SI)

Psychometric properties of the European Heart Failure Self-Care Behaviour Scale (EHFScBS)

Event : EuroHeartCare 2017

  • Session : Education and behavioural aspects
  • Speaker : M Lainscak (Murska Sobota,SI)

Winners of the Heart Failure Awareness Days.

Event : Heart Failure 2017

  • Session : Inaugural Session
  • Speaker : M Lainscak (Murska Sobota,SI)

Global heart failure alliance: role of the national societies.

Event : Heart Failure 2016

  • Session : Alliance against heart failure: call for action
  • Speaker : M Lainscak (Murska Sobota,SI)

LVEF 37% and fully treated, increase heart rate, increased BNP, and QRS of 141ms - What to do? - Clinical case

Event : ESC Congress 2016

  • Session : Common difficult decisions in heart failure
  • Speaker : M Lainscak (Murska Sobota,SI)

Nutritional indices, weight change, and mortality in heart failure: the nutritionDay survey analysis

Event : Heart Failure 2016

  • Session : Metabolism / Diabetes mellitus / Obesity
  • Speaker : M Lainscak (Murska Sobota,SI)

Pulmonary dysfunction.

Event : Heart Failure 2016

  • Session : Organ dysfunction in acute heart failure
  • Speaker : M Lainscak (Murska Sobota,SI)

Chronic lung disease.

Event : ESC Congress 2015

  • Session : Co-morbidities in heart failure - An overview
  • Speaker : M Lainscak (Murska Sobota,SI)

Future direction for research in treatment and biomarker development for cardiotoxicity.

Event : ESC Congress 2015

  • Session : Cardio-Oncology - Where heart failure experts meet cancer
  • Speaker : M Lainscak (Murska Sobota,SI)

Managing cachexia and muscle wasting in heart failure: from appetite stimulants to antibolics.

Event : ESC Congress 2015

  • Session : Nutritional deficiencies and excesses in heart failure
  • Speaker : M Lainscak (Murska Sobota,SI)

Role of drug therapy.

Event : Heart Failure 2015

  • Session : Discharge planning after hospitalisation for decompensated chronic heart failure
  • Speaker : M Lainscak (Murska Sobota,SI)

Chronic obstructive pulmonary disease.

Event : ESC Congress 2014

  • Session : Treating comorbidities in heart failure
  • Speaker : M Lainscak (Murska Sobota,SI)

Will that change my clinical practice?

Event : ESC Congress 2014

  • Session : Emerging biomarkers in heart failure
  • Speaker : M Lainscak (Murska Sobota,SI)

Chronic obstructive pulmonary disease.

Event : ESC Congress 2013

  • Session : Challenges in decompensated heart failure
  • Speaker : M Lainscak (Murska Sobota,SI)

How to adjust medical therapy?

Event : ESC Congress 2013

  • Session : Gut and liver metabolism in heart failure: why bother?
  • Speaker : M Lainscak (Murska Sobota,SI)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are